AirMarshall Posted September 5, 2006 Share Posted September 5, 2006 The US patent for Imitrex, sumatriptan succinate, expires in December 2006. Ranbaxy Pharmaceuticals Ltd received tentative US FDA approval in August 2005 to market a generic sumatriptan succinate. Final approval is typically granted following patent expiration. Reportedly, Mylan Laboratories has also received tentative approval to market as well. Ranbaxy announcement: http://www.ranbaxy.com/newsroom/pressrelease_det.asp?sno=225 Yay for cheap migraine relieve! a.m. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.